Nalbuphine Hydrochloride Injection
Product Images NDC 0404-9766

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hydrochloride (NDC 0404-9766). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure diagram of nalbuphine hydrochloride, showing its molecular framework with hydroxyl groups, a cyclobutylmethyl group, and other functional groups, including the hydrochloride (HCl) component.*

FDA Label Image

Label1.jpg (Label1)

Label for Nalbuphine Hydrochloride injection, 20 mg/mL strength, in a 10 mL multiple-dose vial. The label indicates use for intramuscular, subcutaneous, or intravenous routes. Storage instructions and manufacturer information for Henry Schein, Inc. are included, along with a barcode and lot and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.